All News #Library
Rare Diseases
Spruce Hooks A Commercial Chief To Prep For Rare Disease Launch
09 Mar 2026 //
FIERCE PHARMA
Worldsymposium Showcases Tralensidase Alfa For Sanfilippo
05 Feb 2026 //
BUSINESSWIRE
Spruce Bio Gets FDA Breakthrough Status For (TA-ERT) In MPS IIIB
06 Oct 2025 //
BUSINESSWIRE
Spruce Bio Shows Durable Efficacy of TA-ERT in MPS IIIB
14 Aug 2025 //
BUSINESSWIRE
Spruce inks deal for BioMarin asset, plans 2026 approval filing
16 Apr 2025 //
FIERCE BIOTECH

Market Place
Sourcing Support